175 related articles for article (PubMed ID: 20560705)
1. Selective inhibition of proteins regulating CDK/cyclin complexes: strategy against cancer--a review.
Sarita Rajender P; Ramasree D; Bhargavi K; Vasavi M; Uma V
J Recept Signal Transduct Res; 2010 Aug; 30(4):206-13. PubMed ID: 20560705
[TBL] [Abstract][Full Text] [Related]
2. Deregulated expression of cell-cycle proteins during premalignant progression in SENCAR mouse skin.
Rodriguez-Puebla ML; LaCava M; Gimenez-Conti IB; Johnson DG; Conti CJ
Oncogene; 1998 Oct; 17(17):2251-8. PubMed ID: 9811455
[TBL] [Abstract][Full Text] [Related]
3. ATP-noncompetitive inhibitors of CDK-cyclin complexes.
Orzáez M; Gortat A; Mondragón L; Bachs O; Pérez-Payá E
ChemMedChem; 2009 Jan; 4(1):19-24. PubMed ID: 19039815
[TBL] [Abstract][Full Text] [Related]
4. Cyclins and related kinases in cancer cells.
Malumbres M
J BUON; 2007 Sep; 12 Suppl 1():S45-52. PubMed ID: 17935277
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the interactions between human cdc25C, cdks, cyclins and cdk-cyclin complexes.
Morris MC; Divita G
J Mol Biol; 1999 Feb; 286(2):475-87. PubMed ID: 9973565
[TBL] [Abstract][Full Text] [Related]
6. AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity.
Liu Y; Lu C; Shen Q; Munoz-Medellin D; Kim H; Brown PH
Oncogene; 2004 Oct; 23(50):8238-46. PubMed ID: 15378019
[TBL] [Abstract][Full Text] [Related]
7. Cyclins and the G2/M transition.
Jackman MR; Pines JN
Cancer Surv; 1997; 29():47-73. PubMed ID: 9338096
[TBL] [Abstract][Full Text] [Related]
8. Changes in cyclins and cyclin-dependent kinases induced by DNA damaging agents in a human ovarian cancer cell line expressing mutated or wild-type P53.
Vikhanskaya F; Erba E; D'Incalci M; Broggini M
Exp Cell Res; 1996 Sep; 227(2):380-5. PubMed ID: 8831577
[TBL] [Abstract][Full Text] [Related]
9. The functions of the cdk-cyclin kinase inhibitor p21WAF1.
Boulaire J; Fotedar A; Fotedar R
Pathol Biol (Paris); 2000 Apr; 48(3):190-202. PubMed ID: 10858953
[TBL] [Abstract][Full Text] [Related]
10. [Cell cycle regulation after exposure to ionizing radiation].
Teyssier F; Bay JO; Dionet C; Verrelle P
Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
[TBL] [Abstract][Full Text] [Related]
11. [Changes in the activity of cyclin-kinase complexes governing cell transition from G1 phase to DNA replication phase in E1A + c-Ha-ras transformants transfected with the bcl-2 gene].
Neliudova AM; Aksenov ND; Pospelova TV
Tsitologiia; 2003; 45(2):149-57. PubMed ID: 12722479
[TBL] [Abstract][Full Text] [Related]
12. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
Yin F; Giuliano AE; Law RE; Van Herle AJ
Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771
[TBL] [Abstract][Full Text] [Related]
13. The cyclin box and C-terminus of cyclins A and E specify CDK activation and substrate specificity.
Horton LE; Templeton DJ
Oncogene; 1997 Jan; 14(4):491-8. PubMed ID: 9053846
[TBL] [Abstract][Full Text] [Related]
14. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases.
Wang H; Shao N; Ding QM; Cui J; Reddy ES; Rao VN
Oncogene; 1997 Jul; 15(2):143-57. PubMed ID: 9244350
[TBL] [Abstract][Full Text] [Related]
15. Less-well known functions of cyclin/CDK complexes.
Palmer N; Kaldis P
Semin Cell Dev Biol; 2020 Nov; 107():54-62. PubMed ID: 32386818
[TBL] [Abstract][Full Text] [Related]
16. Targeting Cyclin-Dependent Kinases and Cell Cycle Progression in Human Cancers.
Santo L; Siu KT; Raje N
Semin Oncol; 2015 Dec; 42(6):788-800. PubMed ID: 26615126
[TBL] [Abstract][Full Text] [Related]
17. Cyclin-dependent kinase inhibition: an opportunity to target protein-protein interactions.
Klein MA
Adv Protein Chem Struct Biol; 2020; 121():115-141. PubMed ID: 32312419
[TBL] [Abstract][Full Text] [Related]
18. Roles of CDK/Cyclin complexes in transcription and pre-mRNA splicing: Cyclins L and CDK11 at the cross-roads of cell cycle and regulation of gene expression.
Loyer P; Trembley JH
Semin Cell Dev Biol; 2020 Nov; 107():36-45. PubMed ID: 32446654
[TBL] [Abstract][Full Text] [Related]
19. Purification of Cyclin-Dependent Kinase Fusion Complexes for In Vitro Analysis.
Kõivomägi M
Methods Mol Biol; 2021; 2329():95-109. PubMed ID: 34085218
[TBL] [Abstract][Full Text] [Related]
20. The emerging roles of the CDK/cyclin complexes in antiviral innate immunity.
Zheng C; Tang YD
J Med Virol; 2022 Jun; 94(6):2384-2387. PubMed ID: 34964486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
